Riskpilot← Back to searchSign inGet full accessIPSOMA Aktiebolag
ABActiveOrg 5565752242Benjaminssons Väg 19Medical specialists activities · NACE 8622Est. 19990 employees
Revenue 2024
SEK 48K
-17% vs 2023
EBITDA margin
-64.6%
+64% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -31K
+58% vs 2023
| Revenue | SEK 48K | -17% |
| EBITDA | SEK -31K | +64% |
| Net profit | SEK -31K | +58% |
| Total assets | SEK 602K | -6% |
| Equity | SEK 602K | -5% |
| Employees | 0 | — |
Legal name
IPSOMA Aktiebolag
Org number
5565752242
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 september 1999
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva: - medicinsk och psykologisk behandlingsverksamhet - medicinsk och psykologisk konsultverksamhet - medicinsk och psykologisk forskning med medel från statliga och privata fonder - anordna och tillhandahålla utbildning och handledning inom nämnda områden - driva handel med och förvaltning av fast egendom - driva handel med värdepapper samt därmed förenlig verksamhet.
Address
Benjaminssons Väg 19
Phone
+46317785540
Email
t.sivik@ipsoma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 155 | 25 | 72 | 58 | 48 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 320 | −84 | −1 140 | −86 | −31 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 320 | −84 | −1 140 | −86 | −31 |
| Net financials | −3 | — | −1 | — | — |
| Profit before tax | 218 | −1 | −1 138 | −73 | −31 |
| Tax | −63 | −0 | −0 | −0 | −0 |
| Net profit | 155 | −1 | −1 138 | −73 | −31 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 348 | 2 028 | 890 | 642 | 602 |
| Equity | 1 845 | 1 844 | 706 | 633 | 602 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 404 | 168 | 171 | 9 | 0 |
| Total debt | 404 | 168 | 171 | 9 | — |
EBITDA margin
-64.6%
This company
15.8%
Market median
-509% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-5.1%
This company
18.4%
Market median
-128% vs market
20202024
Net profit margin
-64.6%
This company
8.1%
Market median
-898% vs market
20202024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MT Chief Executive Officer | Chief Executive Officer | 2020 |
LT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
PÅ Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IPSOMA Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marija Tatjana Sikic Sivik | Chief Executive Officer | 0 companies |
| Lars Ture William Sivik | Deputy Chief Executive Officer | 0 companies |
| Per Åke Magnus Leanderson | Authorized Recipient of Service | 0 companies |